Scientific article
OA Policy
English

Atorvastatin-loaded spray-dried PLGA microparticles for local prevention of intimal hyperplasia: Drug release rate optimization and activity on synthetic vascular smooth muscle cells

Publication date2023-01
First online date2022-12-13
Abstract

Intimal hyperplasia (IH) occurs in vascular bypass grafts and is responsible for their failure. This study aimed to encapsulate high payload of atorvastatin (ATV) to efficiently prevent IH, and to evaluate its activity towards synthetic smooth muscle cells (SMC), implicated in IH progression. Poly (lactic-co-glycolic acid) microparticles (MPs) were formulated by spray-drying with three nominal drug loadings: 10, 20 and 30% w/w. We have measured the particle drug load and studied the release of ATV for 90 days with U-HPLC analysis. Scanning electron microscopy, as well as Energy Dispersive X-ray Spectroscopy were used to discuss the differences in the release profiles from the MPs with different drug loadings. The MPs were sterilized by γ-rays and were incubated with synthetic SMC, obtained from pig coronary arteries. We evaluated the impact of ATV release on cell migration, proliferation with flow cytometry, and performed real-time polymerase chain reaction to determine the effect on the dedifferentiation markers. The obtained particles had high drug loads with 76–85% encapsulation efficiencies. Sustained drug release for 90 days was achieved with 10 and 20% ATV-loaded MPs. The comparison of the MPs before and after γ-ray sterilization showed no major influence of the treatment on particle morphology, size or polymer molecular weight, indicating their potential for further use in vitro and in vivo. The ATV-loaded MPs could reverse the synthetic phenotype of SMCs and attenuated their migratory and proliferative capacities.

Keywords
  • Atorvastatin
  • PLGA
  • Microparticles
  • Intimal hyperplasia
  • Smooth muscle cells
  • S100A4 gene
Citation (ISO format)
MELNIK, Tamara et al. Atorvastatin-loaded spray-dried PLGA microparticles for local prevention of intimal hyperplasia: Drug release rate optimization and activity on synthetic vascular smooth muscle cells. In: Journal of drug delivery science and technology, 2023, vol. 79, p. 104076. doi: 10.1016/j.jddst.2022.104076
Main files (1)
Article (Published version)
Identifiers
Journal ISSN1773-2247
265views
122downloads

Technical informations

Creation13/12/2022 11:34:00
First validation13/12/2022 11:34:00
Update time07/02/2024 15:28:53
Status update07/02/2024 15:28:53
Last indexation29/01/2025 17:10:01
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack